Insulin (Lispro mix 75/25)

Primary Indications

Insulin lispro mix 75/25 is used to treat both type 1 and type 2 diabetes. It is prescribed to help manage blood sugar levels in the following situations:

• Type 1 Diabetes: A condition where the pancreas produces little to no insulin.
• Type 2 Diabetes: A condition where the body does not use insulin properly or cannot make enough to maintain normal blood sugar levels.

Role in Diabetes Management

This medication is a premixed insulin that contains two different forms of insulin to provide a dual effect:

• A rapid-acting component that begins working quickly to control blood sugar spikes that occur during and after meals.
• An intermediate-acting component that provides a steady release of insulin to help manage blood sugar levels between meals and overnight.

Effective blood sugar management is a critical part of preventing long-term complications associated with diabetes, such as nerve damage, kidney disease, and vision problems. This insulin is typically used in conjunction with a healthy diet and regular physical activity as part of a complete treatment program.

Dual-Action Control

This medication is a premixed combination of two types of insulin: insulin lispro and insulin lispro protamine. These components work together to manage blood sugar levels at different times:

• Rapid-acting insulin: The insulin lispro portion begins working quickly, typically within 15 minutes. It is designed to handle the rise in blood sugar that occurs immediately after eating.
• Intermediate-acting insulin: The insulin lispro protamine portion is formulated to be absorbed more slowly. This provides a longer-lasting effect that helps maintain stable blood sugar levels between meals and during sleep.

Regulating Blood Glucose

Insulin is a hormone naturally produced by the pancreas that helps the body use or store the sugar (glucose) it gets from food. In individuals with diabetes, the body does not produce enough insulin or cannot use it effectively. This medication replaces the missing insulin to help the body function properly.

When injected, this insulin mixture lowers blood sugar by:

• Helping muscle and fat cells absorb glucose from the bloodstream to be used for energy.
• Reducing the amount of glucose the liver produces and releases into the blood.

Common Side Effects

The most common side effect of insulin lispro mix 75/25 is hypoglycemia (low blood sugar). Other common side effects may include:

• Weight gain
• Swelling in the hands or feet (edema)
• Injection site reactions, such as redness, pain, itching, or swelling
• Skin changes at the injection site, including thickening or pitting (lipodystrophy)
• Itching or mild rash

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious side effects:

• Severe hypoglycemia: Symptoms may include extreme confusion, blurred vision, seizures, or loss of consciousness.
• Low potassium (hypokalemia): Symptoms may include muscle cramps, weakness, or an irregular heartbeat.
• Severe allergic reaction: Symptoms may include a whole-body rash, difficulty breathing, fast heartbeat, sweating, or swelling of the face, tongue, or throat.
• Heart failure: New or worsening shortness of breath, sudden weight gain, or swelling in the ankles or feet, especially if taking certain other diabetes medications called thiazolidinediones (TZDs).

Hypoglycemia

Hypoglycemia (low blood sugar) is the most frequent adverse reaction associated with insulin products. Severe hypoglycemia can lead to seizures, unconsciousness, or death. Symptoms may vary among individuals and can change over time. Monitoring blood glucose levels is essential for safety, especially when changes are made to the insulin dose, meal patterns, or physical activity levels.

Never Share Injection Devices

Insulin pens, needles, or syringes must never be shared between patients, even if the needle is changed. Sharing these devices poses a risk for transmitting bloodborne pathogens, such as hepatitis viruses and HIV.

Hypokalemia

All insulin products, including lispro mix 75/25, cause a shift in potassium from the blood into the cells, which may lead to hypokalemia (low potassium levels). If left untreated, this can cause respiratory paralysis, heart rhythm problems, and death. Monitoring is particularly important for those at risk, such as patients using potassium-lowering medications.

Hypersensitivity and Allergic Reactions

Severe, life-threatening, generalized allergy, including anaphylaxis, can occur with insulin products. If a serious reaction happens, the insulin should be discontinued immediately and emergency medical care sought. Symptoms may include a whole-body rash, shortness of breath, wheezing, fast pulse, or sweating.

Fluid Retention and Heart Failure

When used in combination with certain diabetes medications called thiazolidinediones (TZDs), insulin may cause fluid retention and heart failure. This can occur even if the patient has not had heart problems before. Observation for signs such as swelling of the hands or feet, rapid weight gain, and shortness of breath is necessary.

Administration and Dosing Errors

Accidental mix-ups between insulin products have been reported. It is important to check the insulin label before each injection to ensure the correct product is being used. Changes in insulin strength, manufacturer, type, or method of administration should be made under medical supervision as they may require dose adjustments. This specific mix is a suspension that must be visually inspected and properly resuspended (mixed) before use.

Contraindications

Insulin lispro mix 75/25 should not be used during episodes of hypoglycemia. It is also contraindicated in patients who have a known hypersensitivity to insulin lispro or any of the ingredients in the formulation.

Pregnancy

Maintaining stable blood sugar levels is essential for the health of both the mother and the developing baby. Poorly controlled diabetes during pregnancy can increase the risk of complications, including birth defects, pregnancy-induced high blood pressure, and excessive fetal growth.

Available data from clinical studies have not shown a clear link between insulin lispro and an increased risk of major birth defects or other adverse outcomes. However, insulin needs often change throughout pregnancy. Requirements typically decrease during the first trimester and increase during the second and third trimesters. Close monitoring by a healthcare provider is necessary to adjust dosages as needed.

Breastfeeding

Insulin lispro mix 75/25 is generally considered safe for use while breastfeeding. While small amounts of insulin may pass into breast milk, it is a protein that is typically broken down in the infant's digestive system and is not expected to cause harm to the baby.

Breastfeeding mothers may experience changes in their insulin sensitivity and may require adjustments to their insulin dosage or meal plans. It is important to consult with a healthcare professional to manage blood sugar levels effectively during this period.

Available Forms

This medication is a sterile suspension for subcutaneous injection. It is available in the following formats:

• Vials: Multi-dose glass containers designed for use with a syringe.
• Prefilled Pens: Disposable, multi-dose delivery devices that contain the medication and allow for dose selection.

This product is a mixture of intermediate-acting and rapid-acting insulin. It is intended for injection into the fatty tissue under the skin and should not be used in an insulin pump or administered intravenously.

FDA Approval and Indications

Insulin lispro mix 75/25 is approved by the U.S. Food and Drug Administration (FDA) to treat both type 1 and type 2 diabetes mellitus. It is a combination product consisting of 75% insulin lispro protamine suspension (intermediate-acting) and 25% insulin lispro injection (rapid-acting).

Safety Communications

The FDA has issued safety requirements for the labeling of all multi-dose diabetes pens, including those used for insulin lispro mix 75/25. These labels must clearly state that the pens are for single-patient use only. Sharing these devices between patients, even when the needle is changed, poses a significant risk of transmitting bloodborne pathogens such as HIV or hepatitis viruses.

Regulatory Status

This medication is available only with a prescription from a healthcare provider. It is not currently subject to a Risk Evaluation and Mitigation Strategy (REMS) program or a boxed warning. Regulatory guidelines emphasize the importance of following specific labeling instructions to prevent dosing errors and ensure the medication is administered safely.

Why Weight Gain Occurs

Insulin is an anabolic hormone, meaning it helps the body build and store energy. When you take insulin lispro mix 75/25, your body becomes better at absorbing glucose (sugar) from the bloodstream. If you consume more calories than your body requires for energy, the excess glucose is stored as fat. Furthermore, as blood sugar levels stabilize, the body stops losing glucose through the urine, which can also contribute to weight gain.

Medication Interactions and Fluid Retention

Weight gain can be more pronounced if insulin is used alongside certain other diabetes medications, specifically thiazolidinediones (TZDs) like pioglitazone or rosiglitazone. This combination can cause the body to retain fluid, which may lead to rapid weight gain and increase the risk of heart failure. You should inform your doctor if you experience sudden weight gain or swelling in your ankles or feet.

Management

Managing weight while on insulin therapy typically involves following a specific meal plan and exercise routine as directed by a healthcare provider. It is important to monitor your weight regularly and discuss any significant changes with your medical team to ensure your treatment plan remains appropriate for your needs.